Biodesix, Inc. Secures Medicare Coverage for VeriStrat® Test
6/20/2013 9:03:54 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
BOULDER, Colo.--(BUSINESS WIRE)--Biodesix, Inc., a fully integrated molecular diagnostic company dedicated to personalizing medicine, today announced that Novitas Solutions, the Medicare Administrative Contractor for the region that includes Colorado, has established coverage for the company’s VeriStrat test. VeriStrat, a clinically validated blood-based protein test, helps physicians guide second-line therapy for patients with advanced non-small cell lung cancer (NSCLC). The coverage decision means that more than 49 million eligible Medicare enrollees in the U.S. will now be able to benefit from VeriStrat being a covered diagnostic test, according to specific lung cancer indications outlined by Novitas.
Help employers find you! Check out all the jobs and post your resume.